Reni Benjamin analyst JMP

Currently, out of the existing stock ratings of Reni Benjamin - 128 which are a Buy (95.52%), 6 which are a Hold (4.48%)

Reni Benjamin

Work Performance Price Targets & Ratings Chart

Analyst Reni Benjamin works at JMP and is covering the Healthcare sector with 229 price targets and ratings displayed on 22 stocks. Previously, Reni Benjamin worked at RAYMOND JAMES.

Reni Benjamin's average stock forecast success ratio is 39.01% with an average time for price targets to be met of 101.52 days.

Most recent stock forecast was given on INBX, Inhibrx at 20-Nov-2023.

Wall Street Analyst Reni Benjamin

Analyst best performing recommendations are on CTIC (CTI BIOPHARMA).
The best stock recommendation documented was for CTIC (CTI BIOPHARMA) at 3/2/2022. The price target of $5 was fulfilled within 23 days with a profit of $1.63 (48.37%) receiving and performance score of 21.03.

Average potential price target upside

BCYC Bicycle Therapeutics plc BPMC Blueprint Medicines DCPH Deciphera Pharmaceuticals EFTR INBX Inhibrx INCY yte IOVA Iovance Biotherapeutics SGEN Seattle Genetics STRO Sutro Biopharma VYGR Voyager Therapeutics ALLO Allogene Therapeutics CGEN Compugen Ltd KURA Kura Oncology ACET CTIC CTI BioPharma RGNX REGENXBIO ADAP Adaptimmune Therapeutics plc ADVM Adverum Biotechnologies BCAB CUE SPPI Spectrum Pharmaceuticals URGN UroGen Pharma Ltd

Analyst name


Current price target

Potential distance

Previous price target


Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score



$25.05 (167.56%)


1 months 2 days ago

0/5 (0%)

$19.15 (86.39%)



$29.05 (194.31%)


2 months 23 days ago

0/6 (0%)

$22.9 (78.79%)


2 months 23 days ago

0/3 (0%)

$33.27 (65.08%)



$18.05 (120.74%)


2 months 24 days ago

1/6 (16.67%)

$14.62 (37.19%)




$36.91 (183.72%)


4 months 1 days ago

3/8 (37.5%)

$21.13 (87.61%)


Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Reni Benjamin is most bullish on?

Potential upside of $38.04 has been obtained for INCY (YTE)

Which stock is Reni Benjamin is most reserved on?

Potential downside of -$0 has been obtained for IOVA (IOVANCE BIOTHERAPEUTICS)

What Year was the first public recommendation made by Reni Benjamin?

On 2016

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart